What is Immunome's debt-to-assets?

Immunome (IMNM) reported debt-to-assets of 0× in Q1 2026.

How has Immunome's debt-to-assets changed year-over-year?

Immunome's debt-to-assets decreased by 56.8% year-over-year, from 0× to 0×.

What is the long-term trend for Immunome's debt-to-assets?

Over 4 years (2020 to 2025), Immunome's debt-to-assets has grown at a -15.9% compound annual growth rate (CAGR), from 0× to 0×.

What does debt-to-assets mean?

Total debt divided by total assets at the quarter end. Measures the share of the asset base financed by debt.

Immunome IMNM Debt-to-assets

Debt-to-assets at other companies

PfizerPFE

0.3×0.0×

Arcus BiosciencesRCUS

0.1×+0.1×

Nuvation BioNUVB

0.1×+0.1×

SELLAS Life Sciences Group, Inc.SLS

0×0.0×

ArriVent BioPharma, Inc.AVBP

0×0.0×

IDEAYA Biosciences, Inc.IDYA

0×0.0×

Other financials

Income statement

See full

Revenue--100%

Operating income-$59.3M-32.9%

Net income-$53.8M-29.3%

EPS (diluted)-$0.48+7.7%

Balance sheet

See full

Cash & equivalents$582.7M+126%

Total debt$3.7M-22.6%

Total equity$588.7M+91.7%

Total assets$619.8M+80.9%

Cash flow

See full

Operating cash flow-$58.6M-10.5%

CapEx$3.0M-18.1%

Free cash flow-$61.6M-8.7%

Valuation

See full

Market cap$2.19B+323%

Enterprise value$1.61B+470%

P/S545.2×+498×

Profitability

See full

Operating margin-5,947.9%-12,002pp

Net margin-5,593.8%-11,284pp

FCF margin-5,118.9%-8,601pp

Returns & leverage

See full

Return on equity-50.1%-10.8pp

Debt / equity0×0.0×

Current ratio21.7×+11.2×

Where this comes from

Calculated from Immunome’s reported figures.

total debt/total assets=0×

Based on the most recent quarter.

The official record: Immunome’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Immunome's debt-to-assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Immunome's debt-to-assets?: Immunome (IMNM) reported debt-to-assets of 0× in Q1 2026.
How has Immunome's debt-to-assets changed year-over-year?: Immunome's debt-to-assets decreased by 56.8% year-over-year, from 0× to 0×.
What is the long-term trend for Immunome's debt-to-assets?: Over 4 years (2020 to 2025), Immunome's debt-to-assets has grown at a -15.9% compound annual growth rate (CAGR), from 0× to 0×.
What does debt-to-assets mean?: Total debt divided by total assets at the quarter end. Measures the share of the asset base financed by debt.